Dergiler / İstanbul Journal of Pharmacy / 2020 / Cilt: 50 - Sayı: 1

Studies on the formulation optimization and controlled ionic gelation of chitosan nanoparticles using TPP-HP-β-CD inclusion complex

Sayfa
54–59
Yayın Tarihi
2020-04-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: CS/TPP-HP-β-CD nanoparticle formulation with particle size below 200 nm, high zeta potential and increased physical stability nanoparticles would offer a promising approach especially for hydrophobic drugs to improve their stability, solubility, encapsulation efficiency and in vivo bioavailability.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background and Aims: Ionic gelation strategy is the most common method used for the preparation of chitosan nanoparticles to obtain controlled drug delivery.
📊
Temel Bulgular & Veri:The aim of this study was the development of chitosan nanoparticles using tripolyphosphate-hydroxy propyl β-cyclodextrin or tripolyphosphate-sulfobutyl ether β-cyclodextrin inclusion complex as an alternative to TPP, and hence to increase physical stability, reduce polidispersity index and develop a stable nanocarrier for drug delivery purposes.
💡
Sonuç & Katkı:Conclusion: CS/TPP-HP-β-CD nanoparticle formulation with particle size below 200 nm, high zeta potential and increased physical stability nanoparticles would offer a promising approach especially for hydrophobic drugs to improve their stability, solubility, encapsulation efficiency and in vivo bioavailability.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Chitosan nanoparticles · controlled ionic gelation · cyclodextrins

Abstract

Background and Aims: Ionic gelation strategy is the most common method used for the preparation of chitosan nanoparticles to obtain controlled drug delivery. Although it is a convenient and easy method, it is highly related with particle aggregation, high polidispersity index and insufficient physical/chemical stability. The aim of this study was the development of chitosan nanoparticles using tripolyphosphate-hydroxy propyl β-cyclodextrin or tripolyphosphate-sulfobutyl ether β-cyclodextrin inclusion complex as an alternative to TPP, and hence to increase physical stability, reduce polidispersity index and develop a stable nanocarrier for drug delivery purposes. Methods: The nanoparticles were prepared with the ionic gelation technique. The effects of chitosan percent, pH, and chitosan/tripolyphosphate ratio were investigated to find out the optimum nanoparticles in terms of particle size, polidispersity index and zeta potential. After determining the conditions for the tripolyphosphate-chitosan nanoparticles, the nanoparticles were prepared using tripolyphosphate-hydroxypropyl β-cyclodextrin or tripolyphosphate-sulfobutyl ether β-cyclodextrin to make a comparison with the nanoparticles which were prepared using tripolyphosphate. Results: The chitosan/tripolyphosphate-hydroxypropyl β-cyclodextrin nanoparticles were successfully formulated with 178 ± 84.1 nm particle size, 0.310±0.0134 PDI, 31.2±4.68 mV zeta potential. The interday changes in the measured characteristics were minimized for chitosan/tripolyphosphate-hydroxypropyl β-cyclodextrin nanoparticles as intended. Conclusion: CS/TPP-HP-β-CD nanoparticle formulation with particle size below 200 nm, high zeta potential and increased physical stability nanoparticles would offer a promising approach especially for hydrophobic drugs to improve their stability, solubility, encapsulation efficiency and in vivo bioavailability.

🔖

Bu Makaleye Atıf Yap

AĞARDAN, N. B. M. (2020). Studies on the formulation optimization and controlled ionic gelation of chitosan nanoparticles using TPP-HP-β-CD inclusion complex. İstanbul Journal of Pharmacy, Cilt: 50 - Sayı: 1, 54–59. https://ajindex.com/articles/41736

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Ağardan, N. B., Değim, Z., Yılmaz, Ş., Altıntaş, L., & Topal, T. (2016). The Effectiveness of raloxifene-loaded liposomes and cochleates in breast cancer therapy. AAPS PharmSciTech, 17(4), 968– 977. • Agarwal M, A. M., Shrivastav, N., Pandey, S., Das, R., & Gaur, P. (2018). Preparation of Chitosan Nanoparticles and their In-vitro Characterization. International Journal of Life-Sciences Scientific Research, 4(2), 1713–1720. • Agnihotri, S. A., Mallikarjuna, N. N., & Aminabhavi, T. M. (2004). Recent advances on chitosan-based micro- and nanoparticles in drug delivery. Journal of Controlled Release, 100(1), 5–28. • Ahmed, T. A., & Aljaeid, B. M. (2016). Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery. Drug Design, Development and Therapy, 10, 483–507. • Calvo, P., Remuñan-López, C., Vila-Jato, J. L., & Alonso, M. J. (1997). Chitosan and Chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharmaceutical Research, 14(10), 1431–1436. • Crucho, C. I. C., & Barros, M. T. (2017). Polymeric nanoparticles: A study on the preparation variables and characterization methods. Materials Science and Engineering: C, 80, 771–784. • Elsabahy, M., & Wooley, K. L. (2012). Design of polymeric nanoparticles for biomedical delivery applications. Chemical Society Reviews, 41(7), 2545–2561. • Fulop, Z., Saokham, P., & Loftsson, T. (2014). Sulfobutylether-betacyclodextrin/chitosan nano- and microparticles and their physicochemical characteristics. International Journal of Pharmaceutics, 472(1-2), 282–287. • Grenha, A. (2012). Chitosan nanoparticles: a survey of preparation methods. Journal of Drug Targeting, 20(4), 291–300. • Kapor A, S. S., Nikolic, V., Cvezic, Z., & Rakic, S. (2008). DSC and XRD analysis of inclusion complexes of inclusion complexes of pharmacologically active compounds. Journal of Reseach in Physics, 32(1), 25–31. • Kumari, A., Yadav, S. K., & Yadav, S. C. (2010). Biodegradable polymeric nanoparticles based drug delivery systems. Colloids and Surfaces B: Biointerfaces, 75(1), 1–18. • Loftsson, T., Duchene, D. (2007). Cyclodextrins and their pharmaceutical applications. International Journal of Pharmaceutics, 329(1–2), 1–11. • Mahmoud, A. A., El-Feky, G. S., Kamel, R., & Awad, G. E. A. (2011). Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery